Axis,Extreme1,Extreme2
Specificity,General Delivery,Targeted Delivery
Safety,Low Biocompatibility,High Biocompatibility
Release Control,Immediate Release,Controlled Release
Activation Mechanism,No External Triggering,External Triggering
Treatment Complexity,Single-Drug Delivery,Multi-Drug Delivery
